REGENXBIO Inc. (NASDAQ:RGNX) Q1 2025 Earnings Call Transcript
Operator: Welcome, everyone to the First Quarter 2025 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
Regenxbio Inc. (RGNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 4,794,780 | $34,282,677 | 3.24% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,398,497 | $9,999,254 | +18% | 0.02% |
| 3. | Citadel Investment Group Ken Griffin | 1,027,536 | $7,346,882 | +76% | 0% |
| 4. | Integral Health Asset Management Bhagwan Jay Rao | 925,000 | $6,613,750 | +3% | 0.7% |
| 5. | AQR Capital Management Cliff Asness | 620,595 | $4,437,255 | +2248% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.00 | 49,000 | $1,078,000.00 | 49,000 | 2015-09-22 | Filing | |
| $22.00 | 38,500 | $847,000.00 | 38,500 | 2015-09-22 | Filing | |
| $22.00 | 87,500 | $1,925,000.00 | 1,256,542 | 2015-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.91 | 20,602 | $163,046.29 | 475,103 | 2025-05-12 | Filing | |
| $10.11 | 10,000 | $101,052.00 | 11,286 | 2024-10-01 | Filing | |
| $12.34 | 700 | $8,638.00 | 11,286 | 2024-09-03 | Filing | |
| $11.50 | 9,300 | $106,950.00 | 11,986 | 2024-09-03 | Filing | |
| $15.00 | 100 | $1,500.00 | 11,286 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,454,520 | $38,999,818 | 0% | |
| 2. | 4,364,343 | $31,205,052 | 0% | |
| 3. | 3,472,988 | $24,831,864 | 0% | |
| 4. | 2,066,895 | $14,778,304 | 0% | |
| 5. | 1,147,726 | $8,208,025 | 0% |
News See All
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2024 Earnings Call Transcript
Operator: Welcome everyone to the Fourth Quarter and Year End 2024 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Stocks on Jim Cramer’s Radar
Jim Cramer, the host of Mad Money, addressed some of Wall Street's primary concerns on Tuesday, offering insights into how the White House may interpret the ongoing issues surrounding President Donald...
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q3 2024 REGENXBIO Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q2 2024 REGENXBIO's Earnings Conference Call. All lines have been placed on mute to prevent background noise.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to REGENXBIO's First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
